We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$44.8B
AUM Growth
-$13.1B
Cap. Flow
-$15.3B
Cap. Flow %
-34.2%
Top 10 Hldgs %
11.09%
Holding
1,640
New
75
Increased
562
Reduced
705
Closed
75

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$900M
2
V icon
Visa
V
+$812M
3
MSFT icon
Microsoft
MSFT
+$768M
4
AGN
Allergan Inc
AGN
+$767M
5
MA icon
Mastercard
MA
+$738M

Sector Composition

Rank Sector Weight
1 Healthcare 15.42%
2 Energy 12.55%
3 Financials 12.39%
4 Technology 10.53%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVEO icon
1151
Civeo
CVEO
$379M
$1.08M ﹤0.01%
+3,583
New +$1.07M
HPTX
1152
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.08M ﹤0.01%
41,233
+6,171
+18% +$159K
SRPT icon
1153
Sarepta Therapeutics
SRPT
$1.66B
$1.07M ﹤0.01%
36,000
SASR
1154
DELISTED
Sandy Spring Bancorp Inc
SASR
$1.07M ﹤0.01%
43,000
CAMP
1155
DELISTED
CalAmp Corp.
CAMP
$1.06M ﹤0.01%
2,130
+1,173
+123% +$551K
AMBR
1156
DELISTED
Amber Road Inc
AMBR
$1.05M ﹤0.01%
+65,000
New +$932K
BUSE icon
1157
First Busey Corp
BUSE
$2.52B
$1.03M ﹤0.01%
59,267
ADP icon
1158
Automatic Data Processing
ADP
$100B
$1.03M ﹤0.01%
14,807
-1,709
-10% -$117K
FPO
1159
DELISTED
First Potomac Realty Trust
FPO
$1.01M ﹤0.01%
76,950
-309,907
-80% -$4.03M
BMR
1160
DELISTED
BIOMED REALTY TRUST INC
BMR
$1M ﹤0.01%
45,800
+3,200
+8% +$68K
AHT
1161
Ashford Hospitality Trust
AHT
$21M
$995K ﹤0.01%
92
-10
-10% -$99.3K
GWR
1162
DELISTED
Genesee & Wyoming Inc.
GWR
$994K ﹤0.01%
9,470
+1,410
+17% +$139K
OHI icon
1163
Omega Healthcare
OHI
$15.4B
$992K ﹤0.01%
26,900
-3,300
-11% -$118K
EPM icon
1164
Evolution Petroleum
EPM
$137M
$990K ﹤0.01%
90,371
-21,100
-19% -$242K
EPB
1165
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$989K ﹤0.01%
27,300
BRO icon
1166
Brown & Brown
BRO
$22.9B
$983K ﹤0.01%
+64,000
New +$962K
WRLD icon
1167
World Acceptance Corp
WRLD
$950M
$970K ﹤0.01%
12,766
IRWD icon
1168
Ironwood Pharmaceuticals
IRWD
$611M
$951K ﹤0.01%
74,103
DBD
1169
DELISTED
Diebold Nixdorf Incorporated
DBD
$944K ﹤0.01%
23,500
ESSX
1170
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
$930K ﹤0.01%
382,911
CNW
1171
DELISTED
CON-WAY INC.
CNW
$930K ﹤0.01%
18,443
-14,718
-44% -$661K
STCN
1172
DELISTED
Steel Connect, Inc. Common Stock
STCN
$908K ﹤0.01%
26,004
+10,254
+65% +$372K
DHC
1173
Diversified Healthcare Trust
DHC
$2.26B
$901K ﹤0.01%
38,039
-12,411
-25% -$290K
WPRT
1174
Westport Fuel Systems
WPRT
$36.5M
$901K ﹤0.01%
+5,000
New +$747K
EHC icon
1175
Encompass Health
EHC
$11.2B
$897K ﹤0.01%
31,425

Similar funds

Macquarie Group's Q2 2014 Portfolio in Review

As of Q2 2014, Macquarie Group held 1,640 positions worth $44.8B, down 23% from $57.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $15.3B in Q2 2014, closing 75 positions and reducing 705 holdings. Its most notable exit was ILG, Inc Common Stock, an estimated $83.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Energy and Financials.

Against the trend, Macquarie Group opened a new position in Zebra Technologies worth $55.8M.

  • Macquarie Group's largest Q2 2014 buy was Zebra Technologies: 677,383 shares worth $55.8M.
  • Macquarie Group added most to CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES) in Q2 2014, an estimated $262M increase.
  • Macquarie Group's biggest Q2 2014 reduction was EOG Resources, cutting an estimated $900M.
  • Macquarie Group fully exited ILG, Inc Common Stock in Q2 2014, selling an estimated $83.3M.
  • Macquarie Group's ten largest holdings make up 11% of its $44.8B portfolio in Q2 2014.
  • Macquarie Group opened 75 new positions and closed 75 in Q2 2014.
  • Macquarie Group's portfolio value fell 23% quarter-over-quarter to $44.8B.

Based on Macquarie Group's 13F filing for Q2 2014, filed 14 Aug 2014.